236 related articles for article (PubMed ID: 34389380)
1. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.
Tsvetkov V; Varizhuk A; Kozlovskaya L; Shtro A; Lebedeva O; Komissarov A; Vedekhina T; Manuvera V; Zubkova O; Eremeev A; Shustova E; Pozmogova G; Lioznov D; Ishmukhametov A; Lazarev V; Lagarkova M
Biochimie; 2021 Dec; 191():27-32. PubMed ID: 34389380
[TBL] [Abstract][Full Text] [Related]
2. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
Henss L; Auste A; Schürmann C; Schmidt C; von Rhein C; Mühlebach MD; Schnierle BS
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33830908
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
4. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
Zhang D; Hamdoun S; Chen R; Yang L; Ip CK; Qu Y; Li R; Jiang H; Yang Z; Chung SK; Liu L; Wong VKW
Pharmacol Res; 2021 Oct; 172():105820. PubMed ID: 34403732
[TBL] [Abstract][Full Text] [Related]
5. Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.
Ohgitani E; Shin-Ya M; Ichitani M; Kobayashi M; Takihara T; Kawamoto M; Kinugasa H; Mazda O
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208050
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19.
Wang YQ; Li QS; Zheng XQ; Lu JL; Liang YR
Molecules; 2021 Jun; 26(13):. PubMed ID: 34209485
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.
Du A; Zheng R; Disoma C; Li S; Chen Z; Li S; Liu P; Zhou Y; Shen Y; Liu S; Zhang Y; Dong Z; Yang Q; Alsaadawe M; Razzaq A; Peng Y; Chen X; Hu L; Peng J; Zhang Q; Jiang T; Mo L; Li S; Xia Z
Int J Biol Macromol; 2021 Apr; 176():1-12. PubMed ID: 33548314
[TBL] [Abstract][Full Text] [Related]
8. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2.
Mhatre S; Naik S; Patravale V
Comput Biol Med; 2021 Feb; 129():104137. PubMed ID: 33302163
[TBL] [Abstract][Full Text] [Related]
10. Corilagin and 1,3,6-Tri-
Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
[TBL] [Abstract][Full Text] [Related]
11. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
13. The green tea molecule EGCG inhibits Zika virus entry.
Carneiro BM; Batista MN; Braga ACS; Nogueira ML; Rahal P
Virology; 2016 Sep; 496():215-218. PubMed ID: 27344138
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein.
Sharma N; Murali A; Singh SK; Giri R
Int J Biol Macromol; 2017 Nov; 104(Pt A):1046-1054. PubMed ID: 28666829
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.
de Oliveira A; Adams SD; Lee LH; Murray SR; Hsu SD; Hammond JR; Dickinson D; Chen P; Chu TC
Food Chem Toxicol; 2013 Feb; 52():207-15. PubMed ID: 23182741
[TBL] [Abstract][Full Text] [Related]
16. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells.
Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB
Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067
[TBL] [Abstract][Full Text] [Related]
17. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
18. An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection.
Bimonte S; Forte CA; Cuomo M; Esposito G; Cascella M; Cuomo A
Drug Des Devel Ther; 2021; 15():4447-4454. PubMed ID: 34737551
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
